NanoViricides Says NV-387 Ebola Trial Is Progressing Well
NanoViricides said its Phase II trial of NV-387 oral gummies as an Ebola treatment is progressing well.
Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
1 result loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
NanoViricides said its Phase II trial of NV-387 oral gummies as an Ebola treatment is progressing well.